Jackson Financial Inc.
JXN NYSE Life Insurance Financials FY2019βFY2025
What Jackson Financial Inc. does
No business description yet.
- Legal name
- Jackson Financial Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 24, 2026
- Accession Β· CIK
- 0001822993-26-000022
0001822993
Revenue and margins
Jackson Financial Inc. had $6.7B of revenue in fiscal 2025, up 104.3% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Jackson Financial Inc. returned $892M to shareholders in fiscal 2025. The diluted share count fell 7.3%.
Balance sheet
Cash, debt and the ratios that show how comfortably Jackson Financial Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $2.6B | $4.3B | $2.7B | $3.8B | $5.7B |
| Debt incl. finance leases | $2.6B | $2.9B | $3.0B | $2.0B | $2.0B |
| Debt / equity | 0.3x | 0.3x | 0.3x | 0.2x | 0.2x |
| Total assets | $375.6B | $315.0B | $330.3B | $338.5B | $352.6B |
| Total liabilities | $364.5B | $305.6B | $319.9B | $328.5B | $342.2B |
| Shareholders' equity | $10.4B | $8.6B | $10.2B | $9.8B | $10.0B |
| Net debt (β = net cash) | $26.0M | β$1.4B | $319M | β$1.7B | β$3.7B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 4 | 5 / 7 | 5 / 7 | 5 / 7 | 6 / 7 | 6 / 7 |
| Accruals ratio | β | β1.5% | β0.6% | 0.3% | β1.4% | β1.4% | β1.7% |
| Altman Z'' | β | β | β | β | β | β | β |
7 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $3.5B | $3.5B | $6.4B | $9.8B | $3.1B | $3.3B | $6.7B |
| Interest expense | $99.0M | $88.0M | $37.0M | $98.0M | $109M | $101M | $100M |
| Pretax income | β$811M | β$2.5B | $4.0B | $7.7B | $958M | $1.0B | β$114M |
| Income tax | β$369M | β$854M | $666M | $1.5B | $4.0M | $46.0M | β$186M |
| Net income | β$497M | β$1.6B | $3.4B | $6.2B | $934M | $946M | $27.0M |
| Net income to common | β | β | $3.4B | $6.2B | $899M | $902M | β$17.0M |
| Diluted EPS | β$13.16 | β$24.14 | $36.17 | $69.75 | $10.76 | $11.74 | β$0.24 |
| Diluted shares | 0.04B | 0.07B | 0.09B | 0.09B | 0.08B | 0.08B | 0.07B |
| Cash flow | |||||||
| Cash from operations | $4.4B | $3.7B | $5.7B | $5.2B | $5.3B | $5.8B | $5.8B |
| Depreciation and amortization | $11.0M | $11.0M | $11.0M | β | β | β | β |
| Stock-based compensation | $79.0M | $56.0M | $129M | $131M | $107M | $191M | $132M |
| Share buybacks | $0.0M | $0.0M | $211M | $321M | $306M | $442M | $669M |
| Dividends paid | $0.0M | $0.0M | $50.0M | $186M | $201M | $211M | $223M |
| Dividends and buybacks | $0.0M | $0.0M | $261M | $507M | $507M | $653M | $892M |
| Balance sheet | |||||||
| Cash and short-term investments | $1.9B | $2.0B | $2.6B | $4.3B | $2.7B | $3.8B | $5.7B |
| Total debt | β | $322M | $2.6B | $2.9B | $3.0B | $2.0B | $2.0B |
| Loans, net | β | $10.7B | $11.5B | $11.0B | $10.6B | $9.9B | $10.2B |
| Total assets | β | $353.5B | $375.6B | $315.0B | $330.3B | $338.5B | $352.6B |
| Total liabilities | β | $343.5B | $364.5B | $305.6B | $319.9B | $328.5B | $342.2B |
| Preferred stock | β | β | β | $0.0M | $533M | $533M | $533M |
| Shareholders' equity | $7.3B | $9.4B | $10.4B | $8.6B | $10.2B | $9.8B | $10.0B |
| Margins | |||||||
| Net margin | β14.3% | β46.1% | 53.7% | 62.8% | 30.3% | 28.9% | 0.4% |
| Returns | |||||||
| Return on equity | β6.8% | β19.5% | 34.5% | 65.0% | 9.9% | 9.5% | 0.3% |
| Return on assets | β | β0.5% | 0.9% | 1.8% | 0.3% | 0.3% | 0.0% |
| Return on tangible equity | β6.8% | β17.3% | 32.9% | 71.5% | 8.8% | 9.2% | β0.2% |
| Growth | |||||||
| Revenue growth | β | 2.0% | 79.4% | 54.8% | β68.7% | 6.1% | 104.3% |
| Net income growth | β | β | β | 81.0% | β84.9% | 1.3% | β97.1% |
| EPS growth | β | β | β | 92.8% | β84.6% | 9.1% | β102.0% |
| Share count change | β | 79.1% | 39.6% | β6.1% | β5.8% | β8.1% | β7.3% |
| Financial health | |||||||
| Debt / equity | β | 0.0x | 0.3x | 0.3x | 0.3x | 0.2x | 0.2x |
| Capital allocation | |||||||
| Stock comp / revenue | 2.3% | 1.6% | 2.0% | 1.3% | 3.5% | 5.8% | 2.0% |
| Quality scores | |||||||
| Piotroski F-score | β | β | 5.0 | 5.0 | 5.0 | 6.0 | 6.0 |
| Accruals ratio | β | β1.5% | β0.6% | 0.3% | β1.4% | β1.4% | β1.7% |
Source: SEC EDGAR XBRL filings (CIK 0001822993). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.